Adamas Pharmaceuticals
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Adamas Pharmaceuticals in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Public Employees Retirement System of Ohio ($12) and MAI Capital Management ($0).
- Company
- Adamas Pharmaceuticals
- CUSIP
- 005CVR014
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Public Employees Retirement System of Ohio | 0.00% | No change | 117,000 | $12 |
| MAI Capital Management | 0.00% | No change | 549,557 | $0 |
"% of holder's portfolio" is Adamas Pharmaceuticals's weight in each manager's 13F, not the share of Adamas Pharmaceuticals the manager owns.